Although Lucas et al. suggested that circulating levels of IL-6 and ferritin are less severely elevated in COVID-19 than in some of the other CS disorders [29], high IL-6 levels are nevertheless strongly associated with shorter survival in COVID-19 patient cohorts [1]. This evidence concerns the gene IL6 and COVID-19.